Sanofi, an R&D driven, AI-powered biopharma company, announces the completion of its acquisition of Vicebio Ltd (Vicebio). This acquisition brings an early-stage combination vaccine candidate for ...

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination ...

The science is sound and the evidence is clear; immunization plays a crucial role in helping to protect children’s health ...

A single dose of RSV vaccine effectively protects older veterans against RSV illness, but protection declines over time, notably in immunocompromised individuals.

Americans’ confidence in the Centers for Disease Control and Prevention has plummeted, according to a 2025 National ...

The Gates Foundation rings the alarm on the century's first reversal in progress to save the worlds poorest children, ...

Class H ( (HK:2630) ) has issued an announcement. Vigonvita Life Sciences Co., Ltd. has entered into a license agreement with Simcere Pharmaceutical Group Limited for new indications of its drug ...

Hospitals in the country have seen a noticeable rise in patients seeking treatment for bird flu-like symptoms over October ...

Roche’s point-of-care polymerase chain reaction (PCR) test for pertussis and other Bordetella infections has received ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if ...

Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP 3 ACT™ platform, show excellent in silico free energy binding to the viral target entry protein, ...

Elders need to get shots this season to be protected against major viruses and other illnesses. There are many to choose from ...